Suppression of TRPM7 Inhibits Proliferation, Migration, and Invasion of Malignant Human Glioma Cells

CNS Neuroscience and Therapeutics

Volumn 21, Issue 3, 2015, Pages 252-261

  Leng, Tian Dong ^a   Li, Ming Hua ^b   Shen, Jian Feng ^c   Liu, Ming Li ^a   Li, Xin Bo ^d   Sun, Hua Wei ^e   Branigan, Debbie ^d   Zeng, Zhao ^a   Si, Hong Fang ^f   Li, Jun ^f   Chen, Jeff ^d   Xiong, Zhi Gang ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c ZHEJIANG UNIVERSITY   (China)

^d LEGACY RESEARCH   (United States)

^e SUN YAT SEN UNIVERSITY   (China)

^f ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; Invasion; Migration; Proliferation; TRPM7

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; MESSENGER RNA; SMALL INTERFERING RNA; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; 2-AMINOETHOXYDIPHENYL BORATE; BORON DERIVATIVE; PROTEIN SERINE THREONINE KINASE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM7 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PATCH CLAMP TECHNIQUE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BRAIN NEOPLASMS; CELL CULTURE; CELL MOTION; DRUG EFFECTS; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BLOTTING, WESTERN; BORON COMPOUNDS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; GLIOBLASTOMA; HUMANS; NEOPLASM INVASIVENESS; PATCH-CLAMP TECHNIQUES; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; RNA, SMALL INTERFERING; TRPM CATION CHANNELS;

EID: 84923849876     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12354     Document Type: Article

References (47)

1. Weil RJ. Glioblastoma multiforme-treating a deadly tumor with both strands of RNA. PLoS Med 2006;3:e31.
2. Lehmann-Horn F, Jurkat-Rott K. Voltage-gated ion channels and hereditary disease. Physiol Rev 1999;79:1317-1372.
3. Clapham DE. TRP channels as cellular sensors. Nature 2003;426:517-524.
4. Fleig A, Penner R. The TRPM ion channel subfamily: Molecular, biophysical and functional features. Trends Pharmacol Sci 2004;25:633-639.
5. Ramsey IS, Delling M, Clapham DE. An introduction to TRP channels. Annu Rev Physiol 2006;68:619-647.
6. Minke B. TRP channels and Ca2 + signaling. Cell Calcium 2006;40:261-275.
7. Leng T, Shi Y, Xiong ZG, Sun D. Proton-sensitive cation channels and ion exchangers in ischemic brain injury: New therapeutic targets for stroke? Prog Neurobiol 2014;115:189-209.
8. Schmitz C, Perraud AL, Johnson CO, et al. Regulation of vertebrate cellular Mg2 + homeostasis by TRPM7. Cell 2003;114:191-200.
9. Krapivinsky G, Mochida S, Krapivinsky L, Cibulsky SM, Clapham DE. The TRPM7 ion channel functions in cholinergic synaptic vesicles and affects transmitter release. Neuron 2006;52:485-496.
10. Sun HS, Jackson MF, Martin LJ, et al. Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat Neurosci 2009;12:1300-1307.
11. Du J, Xie J, Zhang Z, et al. TRPM7-mediated Ca2 + signals confer fibrogenesis in human atrial fibrillation. Circ Res 2010;106:992-1003.
12. Jiang J, Li MH, Inoue K, Chu XP, Seeds J, Xiong ZG. Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: Role in cell proliferation. Cancer Res 2007;67:10929-10938.
13. Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H, Ouadid-Ahidouch H. Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Physiol Cell Physiol 2009;297:C493-C502.
14. Sun Y, Sukumaran P, Varma A, Derry S, Sahmoun AE, Singh BB. Cholesterol-induced activation of TRPM7 regulates cell proliferation, migration, and viability of human prostate cells. Biochim Biophys Acta 2014;1843:1839-1850.
15. Mizuno H, Suzuki Y, Watanabe M, et al. Potential role of transient receptor potential (TRP) channels in bladder cancer cells. J Physiol Sci 2014;64:305-314.
16. Guilbert A, Gautier M, Dhennin-Duthille I, et al. Transient receptor potential melastatin 7 is involved in oestrogen receptor-negative metastatic breast cancer cells migration through its kinase domain. Eur J Cancer 2013;49:3694-3707.
17. Meng X, Cai C, Wu J, et al. TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway. Cancer Lett 2013;333:96-102.
18. Middelbeek J, Kuipers AJ, Henneman L, et al. TRPM7 is required for breast tumor cell metastasis. Cancer Res 2012;72:4250-4261.
19. Rybarczyk P, Gautier M, Hague F, et al. Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration. Int J Cancer 2012;131:E851-E861.
20. Brewer GJ, Espinosa J, McIlhaney MP, et al. Culture and regeneration of human neurons after brain surgery. J Neurosci Methods 2001;107:15-23.
21. Li M, Inoue K, Branigan D, et al. Acid-sensing ion channels in acidosis-induced injury of human brain neurons. J Cereb Blood Flow Metab 2010;30:1247-1260.
22. Sun H, Leng T, Zeng Z, Gao X, Inoue K, Xiong ZG. Role of TRPM7 channels in hyperglycemia-mediated injury of vascular endothelial cells. PLoS ONE 2013;8:e79540.
23. Inoue K, Xiong ZG. Silencing TRPM7 promotes growth/proliferation and nitric oxide production of vascular endothelial cells via the ERK pathway. Cardiovasc Res 2009;83:547-557.
24. Shu M, Zheng X, Wu S, et al. Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells. Mol Cancer 2011;19:59-10.
25. Runnels LW, Yue L, Clapham DE. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 2001;291:1043-1047.
26. Aarts M, Iihara K, Wei WL, et al. A key role for TRPM7 channels in anoxic neuronal death. Cell 2003;115:863-877.
27. Liu X, Groschner K, Ambudkar IS. Distinct Ca(2+)-permeable cation currents are activated by internal Ca(2 + )-store depletion in RBL-2H3 cells and human salivary gland cells, HSG and HSY. J Membr Biol 2004;200:93-104.
28. Monteilh-Zoller MK, Hermosura MC, Nadler MJ, Scharenberg AM, Penner R, Fleig A. TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J Gen Physiol 2003;121:49-60.
29. Flemming PK, Dedman AM, Xu SZ, et al. Sensing of lysophospholipids by TRPC5 calcium channel. J Biol Chem 2006;281:4977-4982.
30. Ma HT, Patterson RL, van Rossum DB, Birnbaumer L, Mikoshiba K, Gill DL. Requirement of the inositol trisphosphate receptor for activation of store-operated Ca2 + channels. Science 2000;287:1647-1651.
31. Schindl R, Kahr H, Graz I, Groschner K, Romanin C. Store depletion-activated CaT1 currents in rat basophilic leukemia mast cells are inhibited by 2-aminoethoxydiphenyl borate. Evidence for a regulatory component that controls activation of both CaT1 and CRAC (Ca(2 + ) release-activated Ca(2 + ) channel) channels. J Biol Chem 2002;277:26950-26958.
32. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-498.
33. Cullen BR. RNA interference: Antiviral defense and genetic tool. Nat Immunol 2002;3:597-599.
34. Repesh LA. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 1989;9:192-208.
35. Nadler MJ, Hermosura MC, Inabe K, et al. LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature 2001;411:590-595.
36. Inoue K, Branigan D, Xiong ZG. Zinc-induced neurotoxicity mediated by transient receptor potential melastatin 7 channels. J Biol Chem 2010;285:7430-7439.
37. Schmitz C, Dorovkov MV, Zhao X, Davenport BJ, Ryazanov AG, Perraud AL. The channel kinases TRPM6 and TRPM7 are functionally nonredundant. J Biol Chem 2005;280:37763-37771.
38. Abed E, Moreau R. Importance of melastatin-like transient receptor potential 7 and magnesium in the stimulation of osteoblast proliferation and migration by platelet-derived growth factor. Am J Physiol Cell Physiol 2009;297:C360-C368.
39. Jin J, Desai BN, Navarro B, Donovan A, Andrews NC, Clapham DE. Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering Mg2 + homeostasis. Science 2008;322:756-760.
40. DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114-123.
41. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-996.
42. Lefranc F, Brotchi J, Kiss R. Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 2005;23:2411-2422.
43. Clark K, Langeslag M, van Leeuwen B, et al. TRPM7, a novel regulator of actomyosin contractility and cell adhesion. EMBO J 2006;25:290-301.
44. Callera GE, He Y, Yogi A, et al. Regulation of the novel Mg2 + transporter transient receptor potential melastatin 7 (TRPM7) cation channel by bradykinin in vascular smooth muscle cells. J Hypertens 2009;27:155-166.
45. Hanano T, Hara Y, Shi J, et al. Involvement of TRPM7 in cell growth as a spontaneously activated Ca2 + entry pathway in human retinoblastoma cells. J Pharmacol Sci 2004;95:403-419.
46. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006;25:9-34.
47. Wang J, Xiao L, Luo CH, et al. Overexpression of TRPM7 is associated with poor prognosis in human ovarian carcinoma. Asian Pac J Cancer Prev 2014;15:3955-3958.